FDA resists industry push to nix De Novo inspections in final rule
February 17, 2022 The MedTech industry welcomed the broad goals of the proposed rule published late in 2018; however, pushed back hard against some of its provisions, notably with regard to FDA’s plans to carry out premarket manufacturing inspections. FDA, while making some tweaks to the draft, held firm on the main points of friction … Read more